Teladoc Company Profile (NYSE:TDOC)

About Teladoc (NYSE:TDOC)

Teladoc logoTeladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company's solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. As of July 17, 2017, it served over 7,500 employers, health plans, health systems and other entities. As of July 17, 2017, these clients collectively purchased access to its solution for more than 20 million Members. As of December 31, 2016, it had over 30 health plans as Clients. Its solutions consist of an integrated technology platform, Provider network, consumer engagement strategies and entrenched distribution channels.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Telemedicine Services
  • Sub-Industry: N/A
  • Symbol: NYSE:TDOC
  • CUSIP: N/A
  • Web: www.teladoc.com
Capitalization:
  • Market Cap: $1.89919 billion
  • Outstanding Shares: 54,459,000
Average Prices:
  • 50 Day Moving Avg: $34.41
  • 200 Day Moving Avg: $26.47
  • 52 Week Range: $13.49 - $36.90
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -79.88
  • P/E Growth: -1.96
Sales & Book Value:
  • Annual Revenue: $139.17 million
  • Price / Sales: 13.44
  • Book Value: $6.32 per share
  • Price / Book: 5.44
Profitability:
  • EBIDTA: ($43,100,000.00)
  • Net Margins: -53.58%
  • Return on Equity: -24.73%
  • Return on Assets: -19.40%
Debt:
  • Debt-to-Equity Ratio: 0.12%
  • Current Ratio: 10.75%
  • Quick Ratio: 10.75%
Misc:
  • Average Volume: 945,162 shs.
  • Beta: 0.41
  • Short Ratio: 11.37
 
Frequently Asked Questions for Teladoc (NYSE:TDOC)

What is Teladoc's stock symbol?

Teladoc trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc's earnings last quarter?

Teladoc, Inc. (NYSE:TDOC) announced its earnings results on Monday, May, 8th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.33) by $0.03. The business earned $42.90 million during the quarter, compared to analyst estimates of $42.22 million. Teladoc had a negative return on equity of 24.73% and a negative net margin of 53.58%. The company's revenue for the quarter was up 59.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.40) earnings per share. View Teladoc's Earnings History.

When will Teladoc make its next earnings announcement?

Teladoc is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Teladoc.

What guidance has Teladoc issued on next quarter's earnings?

Teladoc updated its FY17 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of ($0.91)-($0.85) for the period, compared to the Thomson Reuters consensus estimate of ($0.88). The company issued revenue guidance of $180-$185 million, compared to the consensus revenue estimate of $182.79 million.Teladoc also updated its Q2 guidance to ($0.28)-($0.26) EPS.

Where is Teladoc's stock going? Where will Teladoc's stock price be in 2017?

13 brokerages have issued 1 year target prices for Teladoc's stock. Their predictions range from $20.00 to $42.00. On average, they expect Teladoc's stock price to reach $34.00 in the next twelve months. View Analyst Ratings for Teladoc.

What are analysts saying about Teladoc stock?

Here are some recent quotes from research analysts about Teladoc stock:

  • 1. According to Zacks Investment Research, "Teladoc has incurred significant losses in each period since its inception. These losses and accumulated deficit stemmed from the substantial investments made by the company to acquire new clients, build its proprietary network of healthcare providers and develop its technology platform. For 2017, Teladoc is anticipated to report a loss of $46 million–$49 million. Nevertheless, Teladoc is witnessing steady business growth with insurers and customers increasingly embracing tele-health. With five acquisitions completed since its inception, the insurer has expanded its distribution capabilities and broadened its service offering. However, year to date the stock has given a stupendous performance outperforming the Zacks categorized Medical Services industry." (7/17/2017)
  • 2. Cantor Fitzgerald analysts commented, "Strategy makes sense. Boston-based Best Doctors is a medical consultation company focused on second opinions. Its primary customer base lines up nicely with that of TDOC in that it offers cost-containment solutions to employers and payer/provider solutions. In addition to offering expert medical reviews, it provides potential physician referrals to members. With Best Doctors, TDOC expands its range of services into higher-acuity (costs) healthcare delivery. Strategically, the combination of Best Doctors and TDOC makes sense to us. Financials are a different story. TDOC indicates that Best Doctors is expected to generate revenue in excess of $100 million in 2017. This compares with Best Doctors’ 2016 revenue of $92 million (net of divestitures). Our standalone TDOC revenue estimate is $182.5 million for 2017. On an annualized basis, Best Doctors generates about $8.8 million of adjusted EBITDA. TDOC’s 2017 adjusted EBITDA guidance prior to the acquisition was a loss of $19.5-22.5 million. Although Best Doctors should be immediately additive to TDOC’s adjusted EBITDA, added interest expense and more shares outstanding will likely result in a slightly higher loss per share in 2018, before any revenue and cost synergies. Before synergies, the EV/EBITDA valuation for Best Doctors is about 50x (on a run-rate basis), which is expensive." (6/19/2017)
  • 3. Cowen and Company analysts commented, "We are positive on TDOC's partnership with Accolade as it should help drive utilization for members entitled to both benefits. For clients with the combined offering, it has demonstrated improvements in utilization, with mgmt noting ~30% higher utilization. The partnership is already embedded into 2017 guidance, which gives us incremental comfort in the implied utilization ramp." (3/16/2017)
  • 4. Chardan Capital analysts commented, "After market close on Wed., TDOC reported earnings with a beat and a mixed guide for 2017. For 4Q16, Teladoc beat the Street consensus by 2% on the topline and by $0.04 on the bottom line. Management guided to topline growth in 2017 of 48%, in-line with Street consensus and re-affirmed its target of being adj. EBITDA breakeven in 4Q17. Management also guided to more EBITDA loss in 2017 than the Street expected in the first 3 quarters driven by various investments in growth. We adjust our estimates down slightly and in-line with Management Guidance for 2017. We raise our PT to $28 based on multiple expansion we see in 2017 as TDOC's operating characteristics improve relative to valuation comps and investor confidence grows in the company's execution." (3/2/2017)

Who are some of Teladoc's key competitors?

Who are Teladoc's key executives?

Teladoc's management team includes the folowing people:

  • David B. Snow Jr., Independent Chairman of the Board
  • Jason Gorevic, President, Chief Executive Officer, Director
  • Mark J. Hirschhorn, Chief Financial Officer, Chief Operating Officer, Executive Vice President
  • Peter N. Nieves, Executive Vice President, Chief Revenue Officer
  • Gabriel R. Cappucci, Senior Vice President, Chief Accounting Officer, Controller
  • Michael H. King, Chief Sales Officer
  • Adam C. Vandervoort, Chief Legal Officer and Secretary
  • Helen Darling, Independent Director
  • William H. Frist M.D., Independent Director
  • Michael S. Goldstein CPA, Independent Director

When did Teladoc IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who owns Teladoc stock?

Teladoc's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (1.24%), Peregrine Capital Management LLC (1.19%), Public Employees Retirement Association of Colorado (0.63%), Strs Ohio (0.42%), CWM LLC (0.11%) and Russell Investments Group Ltd. (0.08%). Company insiders that own Teladoc stock include Adam C Vandervoort, Dana G Jr Mead, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael H King, Trident Capital Fund Vi Lp and William H Frist. View Institutional Ownership Trends for Teladoc.

Who sold Teladoc stock? Who is selling Teladoc stock?

Teladoc's stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Public Employees Retirement Association of Colorado, CWM LLC, FineMark National Bank & Trust and Daiwa SB Investments Ltd.. Company insiders that have sold Teladoc stock in the last year include Adam C Vandervoort, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael H King and Trident Capital Fund Vi Lp. View Insider Buying and Selling for Teladoc.

Who bought Teladoc stock? Who is buying Teladoc stock?

Teladoc's stock was bought by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Strs Ohio, Westwood Management Corp IL, Russell Investments Group Ltd., Chickasaw Capital Management LLC, US Bancorp DE and Bank of Montreal Can. Company insiders that have bought Teladoc stock in the last two years include Dana G Jr Mead and William H Frist. View Insider Buying and Selling for Teladoc.

How do I buy Teladoc stock?

Shares of Teladoc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teladoc's stock price today?

One share of Teladoc stock can currently be purchased for approximately $34.35.


MarketBeat Community Rating for Teladoc (NYSE TDOC)
Community Ranking:  3.6 out of 5 (  )
Outperform Votes:  230 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  321
MarketBeat's community ratings are surveys of what our community members think about Teladoc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Teladoc (NYSE:TDOC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.85)
Consensus Price Target: $34.00 (1.02% downside)

Analysts' Ratings History for Teladoc (NYSE:TDOC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Piper Jaffray CompaniesReiterated RatingBuy$32.00MediumView Rating Details
6/20/2017William BlairReiterated RatingOutperformHighView Rating Details
6/20/2017Canaccord GenuityReiterated RatingBuy$34.00 -> $42.00HighView Rating Details
6/20/2017Chardan CapitalBoost Price TargetBuy -> Buy$30.00 -> $41.00HighView Rating Details
6/19/2017Cantor FitzgeraldReiterated RatingHold$27.00HighView Rating Details
6/16/2017Robert W. BairdReiterated RatingOutperform$28.00 -> $33.00LowView Rating Details
6/12/2017CIBCBoost Price TargetOutperform$27.00 -> $40.00HighView Rating Details
6/9/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperform$27.00 -> $40.00HighView Rating Details
5/31/2017Cowen and CompanyBoost Price TargetOutperform$29.00 -> $36.00HighView Rating Details
5/17/2017KeyCorpInitiated CoverageOverweight -> Overweight$37.00HighView Rating Details
5/12/2017Craig HallumDowngradeBuy -> Hold$28.00 -> $32.00LowView Rating Details
8/28/2016FBR & CoReiterated RatingBuyN/AView Rating Details
8/4/2016Deutsche Bank AGLower Price TargetBuy$21.00 -> $20.00N/AView Rating Details
6/1/2016Stifel NicolausInitiated CoverageHoldN/AView Rating Details
5/31/2016Jefferies Group LLCReiterated RatingOutperform$25.00N/AView Rating Details
4/1/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
3/7/2016SunTrust Banks, Inc.Lower Price TargetBuy$37.00 -> $21.00N/AView Rating Details
3/3/2016Royal Bank Of CanadaLower Price TargetOutperform$35.00 -> $20.00N/AView Rating Details
10/4/2015Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
9/21/2015J P Morgan Chase & CoReiterated RatingBuyN/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for Teladoc (NYSE:TDOC)
Earnings by Quarter for Teladoc (NYSE:TDOC)
Earnings History by Quarter for Teladoc (NYSE TDOC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017($0.26)N/AView Earnings Details
5/8/2017Q1 2017($0.33)($0.30)$42.22 million$42.90 millionViewListenView Earnings Details
3/1/2017Q416($0.35)($0.31)$36.73 million$37.40 millionViewListenView Earnings Details
10/27/2016Q316($0.36)($0.33)$32.29 million$32.40 millionViewListenView Earnings Details
8/3/2016Q216($0.39)($0.38)$28.20 million$26.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.38)($0.40)$26.64 million$26.90 millionViewListenView Earnings Details
3/2/2016Q415($0.41)($0.39)$21.89 million$22.60 millionViewN/AView Earnings Details
11/2/2015Q315($0.35)($0.35)$19.31 million$19.97 millionViewN/AView Earnings Details
8/12/2015Q215($0.43)($0.46)$17.06 million$18.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Teladoc (NYSE:TDOC)
Current Year EPS Consensus Estimate: $-0.88 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS

Dividends

Dividend History for Teladoc (NYSE:TDOC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Teladoc (NYSE:TDOC)
Insider Ownership Percentage: 5.94%
Institutional Ownership Percentage: 93.69%
Insider Trades by Quarter for Teladoc (NYSE:TDOC)
Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)
Insider Trades by Quarter for Teladoc (NYSE:TDOC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2017Jason N GorevicCEOSell19,991$32.89$657,503.99View SEC Filing  
6/5/2017Jason N GorevicCEOSell13,389$32.89$440,364.21View SEC Filing  
5/25/2017Jason N GorevicCEOSell5,600$29.57$165,592.00View SEC Filing  
5/23/2017Jason N GorevicCEOSell14,400$29.57$425,808.00View SEC Filing  
5/17/2017Mark HirschhornVPSell100,000$27.70$2,770,000.00View SEC Filing  
5/8/2017Jason N GorevicCEOSell15,000$23.11$346,650.00View SEC Filing  
4/19/2017Mark HirschhornVPSell59,100$25.46$1,504,686.00View SEC Filing  
4/19/2017Michael H KingInsiderSell5,000$25.75$128,750.00View SEC Filing  
1/26/2017Mark HirschhornVPSell900$20.00$18,000.00View SEC Filing  
1/24/2017Jason N GorevicCEOSell100,000$15.79$1,579,000.00View SEC Filing  
1/24/2017Trident Capital Fund Vi LpMajor ShareholderSell250,000$15.79$3,947,500.00View SEC Filing  
1/19/2017Michael H KingInsiderSell5,000$19.00$95,000.00View SEC Filing  
1/17/2017Mark HirschhornVPSell10,000$17.84$178,400.00View SEC Filing  
1/9/2017Mark HirschhornVPSell5,000$17.50$87,500.00View SEC Filing  
12/15/2016Mark HirschhornVPSell5,000$16.60$83,000.00View SEC Filing  
12/14/2016Lp Chp IIIMajor ShareholderSell500,000$16.36$8,180,000.00View SEC Filing  
11/16/2016Mark HirschhornVPSell10,000$17.19$171,900.00View SEC Filing  
11/10/2016Mark HirschhornVPSell5,000$17.50$87,500.00View SEC Filing  
10/17/2016Mark HirschhornVPSell5,000$15.52$77,600.00View SEC Filing  
8/16/2016Jason N GorevicCEOSell40,000$17.92$716,800.00View SEC Filing  
8/11/2016Michael H KingInsiderSell25,000$17.20$430,000.00View SEC Filing  
8/8/2016Adam C VandervoortInsiderSell52,865$16.64$879,673.60View SEC Filing  
8/2/2016James K OutlandDirectorSell10,000$18.00$180,000.00View SEC Filing  
7/15/2016Jason N GorevicCEOSell5,000$15.45$77,250.00View SEC Filing  
6/29/2016James K OutlandDirectorSell10,000$15.00$150,000.00View SEC Filing  
6/29/2016Jason N GorevicCEOSell5,000$15.01$75,050.00View SEC Filing  
3/17/2016Dana G Jr. MeadDirectorBuy10,000$10.65$106,500.00View SEC Filing  
9/10/2015William H FristDirectorBuy4,500$22.54$101,430.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Teladoc (NYSE:TDOC)
Latest Headlines for Teladoc (NYSE:TDOC)
Source:
DateHeadline
americanbankingnews.com logoTeladoc Inc (TDOC) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 26 at 7:52 AM
prnewswire.com logoToday's Research Report Coverage on Healthcare Information Services Stocks -- Teladoc, HealthEquity, Medidata ... - PR Newswire (press release)
www.prnewswire.com - July 21 at 7:46 AM
finance.yahoo.com logo3 Stocks Your Children Will Brag About Someday
finance.yahoo.com - July 21 at 7:46 AM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - July 18 at 1:09 PM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 17 at 12:13 PM
feeds.benzinga.com logoTeladoc Completes Acquisition of Best Doctors
feeds.benzinga.com - July 17 at 8:41 AM
americanbankingnews.com logoPiper Jaffray Companies Reaffirms "Buy" Rating for Teladoc, Inc. (TDOC)
www.americanbankingnews.com - July 15 at 10:16 AM
americanbankingnews.com logo Brokerages Expect Teladoc, Inc. (TDOC) Will Announce Quarterly Sales of $44.34 Million
www.americanbankingnews.com - July 14 at 4:21 PM
finance.yahoo.com logo3 of 2017's Fastest Growing Companies
finance.yahoo.com - July 13 at 10:16 AM
americanbankingnews.com logoTeladoc, Inc. (NYSE:TDOC) Expected to Post Earnings of -$0.26 Per Share
www.americanbankingnews.com - July 12 at 8:18 AM
globenewswire.com logoTeladoc to Announce Second Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - July 11 at 9:10 PM
finance.yahoo.com logoThis Company Is Disrupting Doctor's Offices
finance.yahoo.com - July 11 at 8:20 AM
americanbankingnews.com logoTheStreet Lowers Teladoc, Inc. (TDOC) to D
www.americanbankingnews.com - July 7 at 1:52 PM
americanbankingnews.com logoTeladoc's (TDOC) Overweight Rating Reaffirmed at Piper Jaffray Companies
www.americanbankingnews.com - June 25 at 6:44 PM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 23 at 9:24 AM
finance.yahoo.com logoTeladoc Announces Proposed Offering of $200 Million of Convertible Senior Notes due 2022
finance.yahoo.com - June 22 at 2:01 PM
finance.yahoo.com logoTeladoc (TDOC) to Raise Debt for Best Doctors Acquisition
finance.yahoo.com - June 22 at 2:00 PM
finance.yahoo.com logoTeladoc Prices Upsized Offering of $240 Million of Convertible Senior Notes Due 2022
finance.yahoo.com - June 22 at 2:00 PM
streetinsider.com logoTeladoc (TDOC) Proposed Offering of $200M of Convertible Senior Notes due 2022 - StreetInsider.com
www.streetinsider.com - June 21 at 6:07 AM
nasdaq.com logoTeladoc (TDOC) to Buy Best Doctors, Stock Hits New High - Nasdaq
www.nasdaq.com - June 21 at 6:07 AM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Given Outperform Rating at William Blair
www.americanbankingnews.com - June 20 at 8:38 AM
finance.yahoo.com logoTeladoc acquiring Boston medical consultation firm in $440M deal
finance.yahoo.com - June 20 at 8:25 AM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Earns "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - June 20 at 8:07 AM
americanbankingnews.com logoTeladoc's (TDOC) "Hold" Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - June 19 at 9:28 PM
feeds.benzinga.com logoTeladoc to Acquire Best Doctors to Provide a Comprehensive Virtual Healthcare Delivery Platform
feeds.benzinga.com - June 19 at 6:05 PM
americanbankingnews.com logo$44.33 Million in Sales Expected for Teladoc, Inc. (TDOC) This Quarter
www.americanbankingnews.com - June 18 at 10:48 AM
americanbankingnews.com logoTeladoc, Inc. (TDOC) Receives Outperform Rating from Robert W. Baird
www.americanbankingnews.com - June 16 at 4:58 PM
americanbankingnews.com logoZacks: Brokerages Expect Teladoc, Inc. (TDOC) to Announce -$0.25 Earnings Per Share
www.americanbankingnews.com - June 16 at 11:16 AM
nasdaq.com logoTeladoc (TDOC) Up 17% Since Earnings Report: Can It Continue? - Nasdaq
www.nasdaq.com - June 13 at 10:03 PM
finance.yahoo.com logoTeladoc (TDOC) Up 17% Since Earnings Report: Can It Continue?
finance.yahoo.com - June 12 at 7:37 PM
americanbankingnews.com logoCIBC Raises Teladoc, Inc. (TDOC) Price Target to $40.00
www.americanbankingnews.com - June 12 at 5:30 PM
americanbankingnews.com logoTeladoc Inc (TDOC) Given "Outperform" Rating at Oppenheimer Holdings Inc.
www.americanbankingnews.com - June 10 at 11:46 AM
americanbankingnews.com logoJason N. Gorevic Sells 19,991 Shares of Teladoc Inc (TDOC) Stock
www.americanbankingnews.com - June 7 at 10:52 PM
americanbankingnews.com logoTeladoc Inc (TDOC) CEO Jason N. Gorevic Sells 13,389 Shares
www.americanbankingnews.com - June 7 at 10:52 PM
finance.yahoo.com logoEinstein Selects Teladoc as Telehealth Partner to Improve Care for Employees and Community
finance.yahoo.com - June 7 at 9:56 AM
finance.yahoo.com logoTeladoc Hits 52-Week High on Strong Results, Client Wins
finance.yahoo.com - June 5 at 1:37 PM
globenewswire.com logoTeladoc to Participate in Upcoming Investor Conferences - GlobeNewswire (press release)
globenewswire.com - June 3 at 7:32 PM
finance.yahoo.com logoETFs with exposure to Teladoc, Inc. : June 2, 2017
finance.yahoo.com - June 2 at 3:19 PM
finance.yahoo.com logo5 Top Healthcare Technology Trends That Could Make You Rich
finance.yahoo.com - June 2 at 1:48 AM
finance.yahoo.com logoTeladoc to Participate in Upcoming Investor Conferences
finance.yahoo.com - June 2 at 1:48 AM
americanbankingnews.com logoTeladoc's (TDOC) Outperform Rating Reiterated at Cowen and Company
www.americanbankingnews.com - May 31 at 9:56 AM
americanbankingnews.com logoTeladoc Inc (TDOC) CEO Sells $165,592.00 in Stock
www.americanbankingnews.com - May 30 at 8:06 PM
americanbankingnews.com logoTeladoc Inc (TDOC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 29 at 8:38 AM
americanbankingnews.com logoTeladoc Inc (TDOC) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - May 24 at 9:34 PM
americanbankingnews.com logoTeladoc Inc (TDOC) CEO Sells $425,808.00 in Stock
www.americanbankingnews.com - May 24 at 7:40 PM
finance.yahoo.com logoBlog Coverage: Teladoc Expands Virtual Care Capabilities in Texas; Provides TMB Legal Suit Update
finance.yahoo.com - May 23 at 8:57 AM
finance.yahoo.com logoETFs with exposure to Teladoc, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 7:08 PM
americanbankingnews.com logoInsider Selling: Teladoc Inc (TDOC) VP Sells 100,000 Shares of Stock
www.americanbankingnews.com - May 19 at 7:40 PM
finance.yahoo.com logoTeladoc Expands Virtual Care Capabilities in Texas
finance.yahoo.com - May 19 at 6:03 PM
americanbankingnews.com logoKeyCorp Initiates Coverage on Teladoc Inc (TDOC)
www.americanbankingnews.com - May 17 at 5:16 PM

Social

Chart

Teladoc (TDOC) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff